Investigating the Safety and Efficacy of Rituximab and Pembrolizumab in Relapsed/Refractory Waldenström's Macroglobulinaemia
Conditions
- Waldenstrom Macroglobulinemia
Interventions
- DRUG: Pembrolizumab
- DRUG: Rituximab
Sponsor
University College, London
Collaborators